About MMV Capital Partners
Growing companies are constantly balancing the issue of raising capital to fuel their expansion versus taking the dilution associated with raising additional capital. The problem is even more acute when runway extension can be the difference between meeting milestones and achieving an upround or not. MMV provides entrepreneurs with an alternative to address this problem. They have a range of creative debt financing approaches that enable a company to get the best of both worlds: additional capital with limited dilution. A major benefit of MMV is that they deploy their capital quickly and efficiently. Their goal is to make the process as user friendly for their companies as possible. They believe that management time is better spent building their business rather than fundraising. What this means is that typically, upon signing a term sheet, they are able to complete a transaction and provide capital within four weeks. As well, they do not require board representation nor the renegotiation of the shareholder's agreement. Another major advantage of MMV is that they do not require any financial covenants or guarantees from companies or management teams they provide capital to. This means as an entrepreneur, you get full access to their capital to grow your business, and don't have to worry about tripping a covenant and the resulting negative impact on your business. They operate in the technology and life sciences sectors. Their key criteria being that a company has a proprietary product or process that is needed by its customers and clearly differentiates itself from its competitors. Within technology they have been most active in the software and communications arenas. Within life sciences they provide financing to both drug development companies and medical device companies. They have financed a range of companies from those at the pre-product stage of their development to those with over $90 million in annual revenue. Their situations may be different but their